title: Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization.
abstract: Keratoacanthomas are commonly occurring benign skin lesions localized to sun-exposed areas. They typically develop rapidly and may show cellular atypia and infiltration like cutaneous squamous cell carcinomas, but they finally regress spontaneously. This benign lesion shows a high degree of genetic instability as assessed by comparative genomic hybridization, with 35.7% (25 of 70) of the analyzed lesions harboring chromosomal aberrations. The same frequency of genetic imbalance was found in lesions from immunosuppressed organ transplant recipients (36.4%, 20 of 55) and in patients with keratoacanthomas without immunosuppression (33.3%, five of 15), indicating a common pathway in both situations. Recurrent aberrations, given as a fraction of lesions with aberrations, were gains on 8q (20.0%), 1p and 9q (each 16.0%), and deletions on 3p (20.0%), 9p (20.0%), 19p (20.0%), and 19q (16.0%). Many of the most frequently appearing aberrations in keratoacanthomas were not detected in any of the 10 squamous cell carcinomas analyzed, whereas some aberrations were shared by both types of lesions. Aberrations were found in early and late stages of keratoacanthoma development, indicating a role for genetic instability in the progression as well as involution of keratoacanthomas. There were no significant correlations between cytologic atypia and genetic imbalance, or between degree of infiltration and genetic aberrations, although there was a trend for keratoacanthomas with severe atypia to have aberrations. Thus malignant phenotypic development does not appear to be driven by the detected genetic aberrations. More detailed studies of chromosomal areas with recurrent aberrations are needed for the localization of putative genes that determine the biologic behavior of keratoacanthomas, and that may distinguish them from squamous cell carcinomas.
authors.affiliation: Institute and Department of Pathology, University of Oslo, Rikshospitalet, Oslo, Norway. ole.petter.clausen@rikshospitalet.no
authors.forename: Ole Petter F
authors.initials: OP
authors.lastname: Clausen
authors.forename: Marzieh
authors.initials: M
authors.lastname: Beigi
authors.forename: Lars
authors.initials: L
authors.lastname: Bolund
authors.forename: Steen
authors.initials: S
authors.lastname: Kølvraa
authors.forename: Petter Jensen
authors.initials: PJ
authors.lastname: Gjersvik
authors.forename: Gro
authors.initials: G
authors.lastname: Mørk
authors.forename: Paula M
authors.initials: PM
authors.lastname: de Angelis
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000235:genetics; D002869:Chromosome Aberrations; D003937:Diagnosis, Differential; D006801:Humans; D007621:Karyotyping; D007636:Keratoacanthoma / Q000175:diagnosis / Q000235:genetics*; D009693:Nucleic Acid Hybridization; D012871:Skin Diseases / Q000175:diagnosis / Q000235:genetics*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000235:genetics